Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.46 |
| ▸ | MAPT | P10636 | 7/20 | 0.46 |
| ▸ | MEN1 | O00255 | 6/20 | 0.46 |
| ▸ | RAB9A | P51151 | 5/20 | 0.46 |
| ▸ | NPC1 | O15118 | 4/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.40 |
| ▸ | CASP3 | P42574 | 3/20 | 0.40 |
| ▸ | SENP8 | Q96LD8 | 3/20 | 0.40 |
| ▸ | SENP7 | Q9BQF6 | 3/20 | 0.40 |
| ▸ | SENP6 | Q9GZR1 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL40615 | 0.82 | ALDH1A1 (0.57) | ALDH1A1TDP1MAPK1TSHRHSD17B10 | |
| SCHEMBL12270173 | 0.82 | ALDH1A1 (0.57) | ALDH1A1TDP1MAPK1TSHRHSD17B10 | |
| SCHEMBL28233510 | 0.78 | ALDH1A1 (0.52) | ALDH1A1TDP1MAPK1TSHRHSD17B10 | |
| SCHEMBL42818 | 0.78 | — | — | |
| SCHEMBL1870280 | 0.78 | — | — | |
| SCHEMBL316110 | 0.78 | — | — | |
| SCHEMBL27418689 | 0.76 | MIF (0.44) | ALDH1A1TDP1KDM4ECYP2D6LMNA | |
| Hydrochloric Acid SCHEMBL10398523 | 0.76 | TDP1 (0.48) | ALDH1A1TDP1KMT2AMAPTMEN1 | |
| SCHEMBL28147710 | 0.76 | MIF (0.44) | ALDH1A1TDP1KDM4ECYP2D6LMNA | |
| SCHEMBL9418780 | 0.75 | ALDH1A1 (0.92) | ALDH1A1TDP1MAPK1TSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3065722-A2 | NUCLEIC ACID NANOSTRUCTURES FOR IN VIVO AGENT DELIVERY | Dana-Farber Cancer Institute, Inc. (US) | 2016-09-14 | — | — | EP | disclosed |
| WO-2016077581-A1 | ISOSTEVIOL TRIAZOLES AND USES THEREOF | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2016-05-19 | — | — | WO | disclosed |
| EP-2935240-A1 | PRMT5 INHIBITORS AND USES THEREOF | Epizyme, Inc. (US) | 2015-10-28 | — | — | EP | disclosed |
| EP-2935247-A1 | PRMT5 INHIBITORS AND USES THEREOF | Epizyme, Inc. (US) | 2015-10-28 | — | — | EP | disclosed |
| EP-2935241-A1 | PRMT5 INHIBITORS AND USES THEREOF | Epizyme, Inc. (US) | 2015-10-28 | — | — | EP | disclosed |
| WO-2015070080-A2 | NUCLEIC ACID NANOSTRUCTURES FOR IN VIVO AGENT DELIVERY | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2015-05-14 | — | — | WO | disclosed |
| WO-2014100716-A1 | PRMT5 INHIBITORS AND USES THEREOF | Epizyme, Inc. (US) | 2014-06-26 | — | — | WO | disclosed |
| WO-2014100695-A1 | PRMT5 INHIBITORS AND USES THEREOF | Epizyme, Inc. (US) | 2014-06-26 | — | — | WO | disclosed |
| WO-2014100734-A1 | PRMT5 INHIBITORS AND USES THEREOF | Epizyme, Inc. (US) | 2014-06-26 | — | — | WO | disclosed |
| CN-101257966-B | Method and apparatus to fabricate polymer arrays on patterned wafers using electrochemical synthesis | INTEL CORP | 2012-03-21 | — | — | CN | disclosed |
| CN-1916630-A | Method for molecular and nano material based on the electric reading of concrete affair of functionalized electrode, and cmod based device | INTEL CORP (US) | 2007-02-21 | — | — | CN | disclosed |
| WO-2007011658-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2007-01-25 | — | — | WO | disclosed |
| EP-1509537-A2 | CELLULAR ACCUMULATION OF PHOSPHONATE ANALOGS OF HIV PROTEASE INHIBITOR COMPOUNDS AND THE COMPOUNDS AS SUCH | GILEAD SCIENCES, INC. (US) | 2005-03-02 | — | — | EP | disclosed |
| WO-2003090690-A2 | CELLULAR ACCUMULATION OF PHOSPHONATE ANALOGS OF HIV PROTEASE INHIBITOR COMPOUNDS AND THE COMPOUNDS AS SUCH | GILEAD SCIENCES, INC. (US) | 2003-11-06 | — | — | WO | disclosed |
| WO-1999055664-A1 | PREPARATION OF CARBOCYCLIC COMPOUNDS | GILEAD SCIENCES, INC. (US) | 1999-11-04 | — | — | WO | disclosed |
| EP-0821690-A1 | NOVEL COMPOUNDS AND METHODS FOR THERAPY | Ustav Organicke Chemie A Biochemie Akademie Ved Ceske Republiky (CZ) | 1998-02-04 | — | — | EP | disclosed |
| EP-0807118-A2 | NOVEL COMPOUNDS AND METHODS FOR MAKING AND USING SAME | GILEAD SCIENCES, INC. (US) | 1997-11-19 | — | — | EP | disclosed |
| EP-0789695-A2 | THIEPANE COMPOUNDS INHIBITING AND DETECTING HIV PROTEASE | GILEAD SCIENCES, INC. (US) | 1997-08-20 | — | — | EP | disclosed |
| WO-1996026933-A9 | NOVEL SELECTIVE INHIBITORS OF VIRAL OR BACTERIAL NEURAMINIDASES | — | 1996-11-28 | — | — | WO | disclosed |
| WO-1996023801-A2 | NOVEL COMPOUNDS AND METHODS FOR MAKING AND USING SAME | GILEAD SCIENCES, INC. (US) | 1996-08-08 | — | — | WO | disclosed |